Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Version 3.4.2 (2026-02-03) adds Contacts/Locations and Study Status to the record history. The prior revision 3.4.0 (2025-10-06) was removed.
    Difference
    0.3%
    Check dated 2026-02-11T01:42:36.000Z thumbnail image
  3. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and a color-coded change legend; updated revision to v3.4.0 and removed the No FEAR Act Data and the v3.3.4 entry.
    Difference
    0.5%
    Check dated 2026-01-27T22:37:46.000Z thumbnail image
  4. Check
    64 days ago
    Change Detected
    Summary
    Footer metadata changes: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T01:13:16.000Z thumbnail image
  5. Check
    85 days ago
    Change Detected
    Summary
    The page history shows a site release update: Revision: v3.3.2 added and Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:25:42.000Z thumbnail image
  6. Check
    92 days ago
    Change Detected
    Summary
    Version label updated from v3.2.0 to v3.3.1 in the page footer; no visible changes to study data or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T12:42:59.000Z thumbnail image
  7. Check
    100 days ago
    Change Detected
    Summary
    Removed the government funding status notice from the page, and core trial history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T06:22:00.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.